CBR-5884

• Description:

  CBR-5884 is an selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 μM. CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  336.39

• Molecular Formula:

  C14H12N2O4S2

• Notes:

  Research use only, not for human use.

• Receptor:

  PHGDH|serine synthesis

• CAS Number:

  681159-27-3